Galderma Polskasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-10-09
Share capital
93 000,00 PLN
Activity description

Galderma Polska operates in dermatology, spanning injectable aesthetics, dermatological skincare and therapeutic dermatology. Galderma’s portfolio includes Nemluvio, a medicine discussed in connection with the treatment of atopic dermatitis.

Registered address
ul. Puławska 145, 02-715 Warszawa, Poland
Website
galderma.comWebsite active
Social media
Electronic delivery address
AE:PL-53364-88587-RAIVU-17

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 67.94mMedianUSD 874.80kAverageUSD 20.30m
Net profit
This companyUSD 2.28mMedianUSD 28.22kAverageUSD 816.54k
Operating costs
This companyUSD 63.79mMedianUSD 805.63kAverageUSD 19.09m
Assets
This companyUSD 29.12mMedianUSD 541.73kAverageUSD 10.95m

Bank accounts

Registered as a VAT taxpayer on 2001-10-11. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Jul 18, 2012Merger registered

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Alexander Bastiaan Schenk – Management Board Member
Katarzyna Dąbek – Management Board Member
Thomas Marcel Hürlimann – Management Board Member
Zbigniew Tomasz Sobala – President of the Management Board

Manner of representation

Two members of the management board acting jointly are authorized to represent the company, submit declarations and sign on behalf of the company.

Ownership

OwnerSharesShare valueStake
Galderma Pharma S.A.
186$25,121.56100%

Beneficial owners

Person

Competitors

Name
Nivea Polskasp. z o.o.
Roche Diagnostics Polskasp. z o.o.
Servier Polska Servicessp. z o.o.
Gilead Sciences Polandsp. z o.o.
Magnapharm Polandsp. z o.o.
Dermaticsp. z o.o.
Consultronixsp. z o.o.
LR Health & Beauty Systemssp. z o.o.
Ursapharm Polandsp. z o.o.
Vitamed Pharmaceuticalssp. z o.o.

Change history

DateEvent
2025-02-28Name change
2020-03-27Address change
2012-07-06Share capital change
2001-10-09Entered in the register

FAQ

Last updated: 2026-10-07